prof. dr. Jimmy Van den Eynden
- ORCID iD
-
0000-0003-0002-5614
Show
Sort by
-
- Journal Article
- A1
- open access
RUVBL1 and RUVBL2 are druggable MYC effector regulators in neuroblastoma cells
-
Early establishment of small intestine neuroendocrine tumors
-
ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN
-
Deconvoluting fiber type proportions from human skeletal muscle transcriptomics and proteomics data using FibeRtypeR
-
- Journal Article
- A1
- open access
Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived FFPE samples unveils novel paracrine interactions
-
- Journal Article
- A1
- open access
Mechanistic basis of atypical TERT promoter mutations
-
- Journal Article
- A2
- open access
MHC class II genotypes are independent predictors of anti-PD1 immunotherapy response in melanoma
-
Effects of hyperthermia on cisplatin tissue penetration and gene expression in peritoneal metastases : results from a randomized trial in ovarian cancer
-
- Journal Article
- A2
- open access
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN
-
- Journal Article
- A1
- open access
ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic ATR inhibition